1. All
  2. Headlines
    1. Anika Therapeutics: A Recent Greenblatt Small Cap Biotech Pick


      Tue, 16 Sep 2014

      with market cap> $500M on 10/17/2012 identified Exelixis (NASDAQ: EXEL ), Momenta (NASDAQ: MNTA ), Pozen (NASDAQ: POZN ), and Questcor (NASDAQ: QCOR ). An equally weighted portfolio containing these two losers (-62% and -22

    2. A Tale Of 2 Portfolios


      Sat, 13 Sep 2014

      Technologies (NYSE: ESL ), Johnson Controls (NYSE: JCI ), Nexstar Broadcasting Group (NASDAQ: NXST ), Pozen (NASDAQ: POZN ), China Lodging Group (NASDAQ: HTHT ), CVS Caremark (NYSE: CVS ), Home Inns & Hotels Management Inc

    3. Pernix acquires U.S. rights to Treximet


      Wed, 20 Aug 2014

      qtr). GSK assigned the product development and commercialization agreement (PDC Agreement) between GSK and Pozen (NASDAQ: POZN ) to Pernix. Updated 2014 guidance : revenue: $110M - 120M; non-GAAP EBITDA: $22M - 24M. 2015 guidance

    4. Word Doctoring


      Fri, 21 Jun 2013

      resembling a consensus on best practices for money funds. For example, earlier this week two former fund executives, Robert Pozen and Terry Hamacher, penned an Opinion article in The Wall Street Journal that stated support for the first of the SEC's two

    Content Partners